Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

  Business   Nov 3, 2025   0   12  Add to Reading List
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow